{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "This multicentre randomized controlled trial (HAPIrect)"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Eligible patients with adenocarcinoma of the rectum located \u2265\u20025\u2005cm from the anal verge and deemed unsuitable for anterior resection with anastomosis were randomized (1:1) intraoperatively to either HP or iAPE."
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligible patients with adenocarcinoma of the rectum located \u2265\u20025\u2005cm from the anal verge and deemed unsuitable for anterior resection with anastomosis were randomized (1:1) intraoperatively to either HP or iAPE."
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomized (1:1) intraoperatively to either HP or iAPE."
      },
      "Objective": {
        "score": 1,
        "evidence": "The aim of this trial was to determine 30-day postoperative surgical complication rates after Hartmann\u2019s procedure (HP) versus intersphincteric abdominoperineal excision (iAPE) in patients with rectal cancer who were not suitable for restorative surgery."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was 30-day postoperative surgical complications."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "randomized (1:1) intraoperatively to either HP or iAPE."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Of 194 eligible patients, 163 were randomized (80 patients to HP and 83 to iAPE)."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Logistic regression in the intention-to-treat population was the primary method used to compare the surgical approaches."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "In the HP and iAPE groups, the surgical complication rate was 39% and 43%, respectively (odds ratio (OR) for HP 0.83; 95% confidence interval (c.i.) 0.44 to 1.54; P = 0.549)"
      },
      "Harms": {
        "score": 1,
        "evidence": "The overall complication rate (including both medical and surgical complications) was 45% and 49% in the HP and iAPE groups, respectively ( P = 0.574)."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Registration number: NCT01995396 ( http://www.clinicaltrials.gov )."
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 17,
    "max_score": 25
  },
  "model": "gpt-4o"
}